1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile

C166H213FN26O17S — CID 161241109

IUPAC1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile
SMILESCN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccc(S(C)(=O)=O)cc1F)C(=O)N2CC1CC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccccc1C(N)=O)C(=O)N2CC1(O)CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(c1ccccc1C#N)C(=O)N2CC1(O)CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(c1cnc(C#N)nc1)C(=O)N2CC1(O)CCC1.COC1(CCN2C(=O)N(c3ccccc3C(N)=O)CC23CCC(c2ccccc2)(N(C)C)CC3)CCC1.COC1(CCN2C(=O)N(c3cnc(C)nc3)CC23CCC(c2ccccc2)(N(C)C)CC3)CCC1.O=CO
InChIInChI=1S/C30H40N4O3.C28H39N5O2.C28H36N4O3.C27H34FN3O3S.C27H32N4O2.C25H30N6O2.CH2O2/c1-32(2)30(23-10-5-4-6-11-23)18-16-28(17-19-30)22-33(25-13-8-7-12-24(25)26(31)35)27(36)34(28)21-20-29(37-3)14-9-15-29;1-22-29-19-24(20-30-22)32-21-26(33(25(32)34)18-17-27(35-4)11-8-12-27)13-15-28(16-14-26,31(2)3)23-9-6-5-7-10-23;1-30(2)28(21-9-4-3-5-10-21)17-15-26(16-18-28)19-31(23-12-7-6-11-22(23)24(29)33)25(34)32(26)20-27(35)13-8-14-27;1-29(2)27(21-7-5-4-6-8-21)15-13-26(14-16-27)19-30(25(32)31(26)18-20-9-10-20)24-12-11-22(17-23(24)28)35(3,33)34;1-29-27(22-9-3-2-4-10-22)16-14-25(15-17-27)19-30(23-11-6-5-8-21(23)18-28)24(32)31(25)20-26(33)12-7-13-26;1-27-25(19-6-3-2-4-7-19)12-10-23(11-13-25)17-30(20-15-28-21(14-26)29-16-20)22(32)31(23)18-24(33)8-5-9-24;2-1-3/h4-8,10-13H,9,14-22H2,1-3H3,(H2,31,35);5-7,9-10,19-20H,8,11-18,21H2,1-4H3;3-7,9-12,35H,8,13-20H2,1-2H3,(H2,29,33);4-8,11-12,17,20H,9-10,13-16,18-19H2,1-3H3;2-6,8-11,29,33H,7,12-17,19-20H2,1H3;2-4,6-7,15-16,27,33H,5,8-13,17-18H2,1H3;1H,(H,2,3)
InChIKeyUZZZLCCUGQIZKO-UHFFFAOYSA-N
MW2895.76 g/mol
LogP24.65
Rot. Bonds37

About 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile

1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile (PubChem CID 161241109) has the molecular formula C166H213FN26O17S and a molecular weight of 2895.76 g/mol. Its IUPAC name is 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile.

Molecular Properties

Compound Name1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile
PubChem CID161241109
Molecular FormulaC166H213FN26O17S
Molecular Weight2895.76 g/mol
Exact Mass2893.63
IUPAC Name1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile
SMILESCN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccc(S(C)(=O)=O)cc1F)C(=O)N2CC1CC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccccc1C(N)=O)C(=O)N2CC1(O)CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(c1ccccc1C#N)C(=O)N2CC1(O)CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(c1cnc(C#N)nc1)C(=O)N2CC1(O)CCC1.COC1(CCN2C(=O)N(c3ccccc3C(N)=O)CC23CCC(c2ccccc2)(N(C)C)CC3)CCC1.COC1(CCN2C(=O)N(c3cnc(C)nc3)CC23CCC(c2ccccc2)(N(C)C)CC3)CCC1.O=CO
InChIInChI=1S/C30H40N4O3.C28H39N5O2.C28H36N4O3.C27H34FN3O3S.C27H32N4O2.C25H30N6O2.CH2O2/c1-32(2)30(23-10-5-4-6-11-23)18-16-28(17-19-30)22-33(25-13-8-7-12-24(25)26(31)35)27(36)34(28)21-20-29(37-3)14-9-15-29;1-22-29-19-24(20-30-22)32-21-26(33(25(32)34)18-17-27(35-4)11-8-12-27)13-15-28(16-14-26,31(2)3)23-9-6-5-7-10-23;1-30(2)28(21-9-4-3-5-10-21)17-15-26(16-18-28)19-31(23-12-7-6-11-22(23)24(29)33)25(34)32(26)20-27(35)13-8-14-27;1-29(2)27(21-7-5-4-6-8-21)15-13-26(14-16-27)19-30(25(32)31(26)18-20-9-10-20)24-12-11-22(17-23(24)28)35(3,33)34;1-29-27(22-9-3-2-4-10-22)16-14-25(15-17-27)19-30(23-11-6-5-8-21(23)18-28)24(32)31(25)20-26(33)12-7-13-26;1-27-25(19-6-3-2-4-7-19)12-10-23(11-13-25)17-30(20-15-28-21(14-26)29-16-20)22(32)31(23)18-24(33)8-5-9-24;2-1-3/h4-8,10-13H,9,14-22H2,1-3H3,(H2,31,35);5-7,9-10,19-20H,8,11-18,21H2,1-4H3;3-7,9-12,35H,8,13-20H2,1-2H3,(H2,29,33);4-8,11-12,17,20H,9-10,13-16,18-19H2,1-3H3;2-6,8-11,29,33H,7,12-17,19-20H2,1H3;2-4,6-7,15-16,27,33H,5,8-13,17-18H2,1H3;1H,(H,2,3)
InChIKeyUZZZLCCUGQIZKO-UHFFFAOYSA-N
XLogP24.65
TPSA514.23 Ų
H-Bond Donors8
H-Bond Acceptors28
Rotatable Bonds37
Heavy Atoms211
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002895.76
LogP ≤ 524.65
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile?
The IUPAC name of 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile (CID 161241109) is 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile.
What is the SMILES notation for 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile?
The canonical SMILES for 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile is CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccc(S(C)(=O)=O)cc1F)C(=O)N2CC1CC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccccc1C(N)=O)C(=O)N2CC1(O)CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(c1ccccc1C#N)C(=O)N2CC1(O)CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(c1cnc(C#N)nc1)C(=O)N2CC1(O)CCC1.COC1(CCN2C(=O)N(c3ccccc3C(N)=O)CC23CCC(c2ccccc2)(N(C)C)CC3)CCC1.COC1(CCN2C(=O)N(c3cnc(C)nc3)CC23CCC(c2ccccc2)(N(C)C)CC3)CCC1.O=CO.
What is the InChIKey of 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile?
The InChIKey is UZZZLCCUGQIZKO-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H40N4O3.C28H39N5O2.C28H36N4O3.C27H34FN3O3S.C27H32N4O2.C25H30N6O2.CH2O2/c1-32(2)30(23-10-5-4-6-11-23)18-16-28(17-19-30)22-33(25-13-8-7-12-24(25)26(31)35)27(36)34(28)21-20-29(37-3)14-9-15-29;1-22-29-19-24(20-30-22)32-21-26(33(25(32)34)18-17-27(35-4)11-8-12-27)13-15-28(16-14-26,31(2)3)23-9-6-5-7-10-23;1-30(2)28(21-9-4-3-5-10-21)17-15-26(16-18-28)19-31(23-12-7-6-11-22(23)24(29)33)25(34)32(26)20-27(35)13-8-14-27;1-29(2)27(21-7-5-4-6-8-21)15-13-26(14-16-27)19-30(25(32)31(26)18-20-9-10-20)24-12-11-22(17-23(24)28)35(3,33)34;1-29-27(22-9-3-2-4-10-22)16-14-25(15-17-27)19-30(23-11-6-5-8-21(23)18-28)24(32)31(25)20-26(33)12-7-13-26;1-27-25(19-6-3-2-4-7-19)12-10-23(11-13-25)17-30(20-15-28-21(14-26)29-16-20)22(32)31(23)18-24(33)8-5-9-24;2-1-3/h4-8,10-13H,9,14-22H2,1-3H3,(H2,31,35);5-7,9-10,19-20H,8,11-18,21H2,1-4H3;3-7,9-12,35H,8,13-20H2,1-2H3,(H2,29,33);4-8,11-12,17,20H,9-10,13-16,18-19H2,1-3H3;2-6,8-11,29,33H,7,12-17,19-20H2,1H3;2-4,6-7,15-16,27,33H,5,8-13,17-18H2,1H3;1H,(H,2,3).
What are the key properties of 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile?
1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile has a molecular weight of 2895.76 g/mol, XLogP of 24.65, 37 rotatable bonds, 8 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(cyclopropylmethyl)-8-(dimethylamino)-3-(2-fluoro-4-methylsulfonylphenyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-3-(2-methylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-1-[2-(1-methoxycyclobutyl)ethyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzamide;formic acid;2-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]benzonitrile;5-[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]pyrimidine-2-carbonitrile is sourced from PubChem (CID 161241109), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).